Company Monitoring Page for Roche

latest headlines for company on cafepharma

Roche dumps its PhIII PI3K effort on taselisib after researchers track poor survival edge, harsh side effects for breast cancer
Endpoints
Sun, 06/3/18 - 10:29 am
Tags:
Roche, taselisib, fulvestrant, metastatic breast cancer, ASCO 2018
ASCO18: Tecentriq scores again in lung cancer, but Keytruda looms in background
Biopharma Dive
Sat, 06/2/18 - 01:39 pm
Tags:
Roche, Tecentriq, ASCO 2018, chemotherapy, advanced squamous non-small cell lung cancer
Roche scraps €120M SMA drug after hitting ‘many difficulties’
Fierce Biotech
Fri, 06/1/18 - 11:25 pm
Tags:
Roche, SMA, spinal muscular atrophy, Olesoxime
5 Best-Selling Orphan Drugs in the U.S.
Motley Fool
Wed, 05/30/18 - 09:13 pm
Tags:
orphan drugs, Celgene, Revlimid, Roche, Rituxan, Teva Pharmaceutical, Copaxone, Opdivo, Bristol-Myers Squibb, Merck, Keytruda
Celltrion resubmits Rituxan candidate in US, Herceptin version to follow
Biopharma Reporter
Wed, 05/30/18 - 08:29 pm
Tags:
Celltrion, Rituxan, biosimilars, FDA, Herceptin, Roche, Biogen, CT-P10
Roche Up, J&J Down as Cancer Drug Combos Yield More Mixed Results
Xconomy
Tue, 05/29/18 - 11:36 am
Tags:
clinical trials, Roche, Genentech, Genmab, JNJ, cancer, Tecentriq, Darzalex
Roche’s Tecentriq scores again on a pivotal frontline lung cancer trial, positioning them against Merck, Bristol-Myers
Endpoints
Tue, 05/29/18 - 08:54 am
Tags:
Roche, Tecentriq, anti-PD-L1, non-squamous non-small cell lung cancer, Merck, Bristol-Myers Squibb
Alzheimer’s Disease: Companies Weigh Revised FDA Draft Guidance
RAPS.org
Tue, 05/22/18 - 11:06 am
Tags:
Alzheimer's disease, FDA, Roche, AstraZeneca, Bioclinica, Eli Lilly, Denali Therapeutics
FDA warns of decreased survival in 2 studies of Keytruda, Tecentriq
Biopharma Dive
Mon, 05/21/18 - 09:44 pm
Tags:
FDA, clinical trials, oncologists, bladder cancer, Merck, Keytruda, Roche, Tecentriq
Roche drug dramatically reduces bleeds in key hemophilia tests
Reuters
Mon, 05/21/18 - 10:13 am
Tags:
Roche, Hemlibra, clinical trials, hemophilia A
Roche pens death notice for NewLink IDO/TDO cancer collaboration
Fierce Biotech
Tue, 05/15/18 - 09:29 pm
Tags:
Roche, NewLink Genetics, IDO/TDO inhibitors, drug development
Roche Tecentriq and Cotellic Combination Fails Ph III Trial in Colorectal Cancer
CP Wire
Thu, 05/10/18 - 09:57 am
Tags:
Roche, Exelixis, Tecentriq, Cotellic, colorectal cancer
Thu, 05/10/18 - 09:52 am
Tags:
Roche, Exelixis, Tecentriq, Cotellic
FDA promises Roche a snap decision on Tecentriq triple for frontline lung cancer as it falls even further behind Merck, Bristol-Myers
Endpoints
Mon, 05/7/18 - 09:50 am
Tags:
Roche, Tecentriq, FDA, Genentech, lung cancer
Mundipharma and Celltrion Heathcare Launch Herceptin Biosimilar Herzuma in Europe
CP Wire
Thu, 05/3/18 - 09:33 am
Tags:
Herzuma, biosimilars, trastuzumab, Europe, Herceptin, Roche, Mundipharma, Celltrion
Flatiron Health, Purchased By Roche, Signs Three-Year Deal With Bristol-Myers
Forbes
Wed, 05/2/18 - 10:49 am
Tags:
Flatiron Health, M&A, Roche, Bristol-Myers Squibb, real-world evidence
NeoImmuneTech and Roche Collaborate in Clinical Trial of HyLeukin-7 in Combination with a PD-L1 Checkpoint Inhibitor in Advanced High-Risk Skin Cancers
CP Wire
Wed, 05/2/18 - 09:58 am
Tags:
NeoImmune Tech, Genexine, Roche, R&D, melanoma, Merkel cell carcinoma, cutaneous squamous cell carcinoma
Tue, 05/1/18 - 08:32 pm
Tags:
NeoImmune Tech, Genexine, Roche, HyLeukin-7, checkpoint inhibitors, melanoma
Ocrevus fuels fast start to year for Roche
Biopharma Dive
Thu, 04/26/18 - 07:21 pm
Tags:
Roche, earnings, Ocrevus
Roche flags first case of anti-drug antibodies that forced a patient to drop would-be blockbuster Hemlibra
Endpoints
Thu, 04/26/18 - 11:11 am
Tags:
Roche, hemophilia, Hemlibra, anti-drug antibodies

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.